What is Arcus Biosciences's accrued investment income?

Arcus Biosciences (RCUS) reported accrued investment income of $4M in Q1 2026.

How has Arcus Biosciences's accrued investment income changed year-over-year?

Arcus Biosciences's accrued investment income decreased by 33.3% year-over-year, from $6M to $4M.

What is the long-term trend for Arcus Biosciences's accrued investment income?

Over 5 years (2020 to 2025), Arcus Biosciences's accrued investment income has grown at a 50.4% compound annual growth rate (CAGR), from $649K to $5M.

Arcus Biosciences RCUS Accrued investment income

Accrued investment income at other companies

SiriusPointSPNT

$41.4M-1.7%

Voya FinancialVOYA

$426M-0.7%

Mercury GeneralMCY

$73.38M+18.6%

Palomar Holdings, Inc.PLMR

$12.83M+49.3%

Lincoln NationalLNC

$1.17B+3.2%

NMI Holdings Inc.NMIH

$29.73M+25.7%

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.54B+226%

Enterprise value$3.46B+275%

P/S15×+7.3×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:InterestReceivableCurrent.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's accrued investment income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's accrued investment income?: Arcus Biosciences (RCUS) reported accrued investment income of $4M in Q1 2026.
How has Arcus Biosciences's accrued investment income changed year-over-year?: Arcus Biosciences's accrued investment income decreased by 33.3% year-over-year, from $6M to $4M.
What is the long-term trend for Arcus Biosciences's accrued investment income?: Over 5 years (2020 to 2025), Arcus Biosciences's accrued investment income has grown at a 50.4% compound annual growth rate (CAGR), from $649K to $5M.